NCT06811649 Comparison of Echo-assisted ALR Technique and Traditional ALR Technique for the Placement of an Epidural Catheter in the Obstetric Patient
| NCT ID | NCT06811649 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 146 participants |
| Start Date | 2023-07-17 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 146 participants in total. It began in 2023-07-17 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized, open-label, single-center clinical trial. The purpose of the study is to understand whether the aid of ultrasound assessment is useful in improving the competence of resident. Specifically, to demonstrate how the aid of echo-assistance in the evaluation of the spine increases the atraumatic success rate (primary objective) and reduces the number of complications (particularly, the number of attempts needed and the rate of dura puncture) (secondary objective) in physicians in specialty training. Pregnant patients requiring peridural analgesia will be assigned to the intervention or control group by simple randomization.
Eligibility Criteria
Inclusion Criteria: * Pregnant patients \>18 years of age with no BMI (Body Mass Index) limitation * Pregnant patients requiring partoanalgesia * Obtaining informed consent for study participation Exclusion Criteria: * Patients with contraindications to epidural catheter placement * Endocranial hypertension * Coagulopathies * Severe thrombocytopenia \< 75,000 per mm\^3.
Contact & Investigator
Aurora Guglielmetti, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06811649 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06811649 currently recruiting?
Yes, NCT06811649 is actively recruiting participants. Contact the research team at aurora.guglielmetti@aosp.bo.it for enrollment information.
Where is the NCT06811649 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06811649 clinical trial?
NCT06811649 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Aurora Guglielmetti, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 146 participants.